InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001127602-22-013522 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-05 2022-05-04 MRK Klobuchar Michael A EVP - Chief Strategy Off F - Tax $87.10 -436 15.3K -3% -$38.0K
D 2022-05-05 2022-05-04 MRK Klobuchar Michael A EVP - Chief Strategy Off M - OptEx $87.10 +885 15.8K +6% +$77.1K
D 2022-05-05 2022-05-04 MRK Klobuchar Michael A EVP - Chief Strategy Off M - OptEx $0.00 -885 1,772 -33% $0
D 2022-05-05 2022-05-03 MRK Klobuchar Michael A EVP - Chief Strategy Off A - Grant $0.00 +25.2K 25.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-04 F D 436 $87.10 15,338.93 D — — (F1) Holdings include shares acquired in dividend reinvestment transactions.
2 Common Common Stock 2022-05-04 M A 885 $87.10 15,774.93 D — —
3 Derivative Restricted Stock Unit 2022-05-04 M D 885 $0.00 1,772 D — · 2022-05-04 to 2024-05-04 885 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F4) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
4 Derivative Stock Option (Right to Buy) 2022-05-03 A A 25,243 $0.00 25,243 D $87.10 · 2023-05-03 to 2032-05-02 25,243 Common Stock (F5) The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.